Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma.
Imran Noorani1,2,3, Magnus Haughey4, Jens Luebeck5
1Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
Cancer Discovery
|September 8, 2025
Summary
Extrachromosomal DNA (ecDNA) oncogene amplification drives cancer resistance. This study reveals oncogene-specific ecDNA evolution in glioblastoma, showing EGFR-ecDNA accumulation precedes clonal expansion, impacting treatment resistance.
Area of Science:
- Genomics
- Cancer Biology
- Computational Biology
Background:
- Extrachromosomal DNA (ecDNA) amplification of oncogenes is a hallmark of cancer, linked to treatment resistance and poor prognosis.
- The spatiotemporal evolution and heterogeneity of ecDNA remain poorly understood, hindering therapeutic strategies.
Purpose of the Study:
- To investigate the spatiotemporal evolution of ecDNA in human glioblastoma (GBM).
- To understand oncogene-specific patterns of ecDNA heterogeneity and their evolutionary trajectories.
Main Methods:
- Integration of computational modeling with genomic data from 94 treatment-naive human GBM samples.
- Analysis of spatial patterns and evolutionary properties of ecDNA-amplified oncogenes.
Main Results:
- Observed oncogene-specific spatial heterogeneity in ecDNA, driven by random segregation and differential fitness advantages.
- EGFR-ecDNAs, unlike PDGFRA-ecDNAs, accumulate before clonal expansions, conferring significant fitness advantages and high abundance.
- Variant EGFR-ecDNAs, including EGFRvIII, originate from wild-type EGFR-ecDNAs, appearing early and reaching high levels.
Conclusions:
- The oncogenic makeup of ecDNA dictates distinct evolutionary paths in GBM.
- New concepts like ecDNA clonality and heteroplasmy necessitate refined evolutionary interpretations of GBM genomic data.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Cancer-Critical Genes I: Proto-oncogenes
11.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.2K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K


